Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Life Science Products Market – Insights

Life science, also referred as biology, is the study of life and living things. It includes anatomy, animal biology, bacteriology, biochemistry, cell biology, ecology, evolutionary biology, genetics, molecular biology, plant biology, physiology, and virology. Life science plays major role in drug discovery, tissue engineering, drug screening, forensic testing, and genetic analysis.

Statistics:

The global life science products market is estimated to account for US$ 4,735.8 Mn in terms of value by the end of 2027.

Global Life Science Products Market: Drivers

Increasing funding in the life science sector is expected to boost growth of the global life science products market over the forecast period. For instance, in February 2020, Purdue-affiliated Amplified Sciences LLC and Brightlamp Inc. received a grant of US$ 250,000 each from the Purdue Foundry Investment Fund for R&D in life science technologies.

Moreover, R&D in rare diseases is also expected to aid in growth of the market. For instance, Oraxion Therapeutics, Inc., a subsidiary of India-based Aten Porus, is undergoing preclinical and efficacy study of the drug, ORX-301, which can be used in the treatment of FSGS. In February 2018, Oraxion Therapeutics, Inc. entered into an Option Agreement with a U.S-based biopharmaceutical company. Under the, agreement, the U.S.-based company gets exclusive rights for further clinical studies and license of ORX-301 in the U.S.

Asia Pacific region held dominant position in the global life science products market in 2019, accounting for 42.6% share in terms of value, followed by North America.

Figure 1. Global Life Science Products Market Share (%), by Region, 2019

Life Science Products  | Coherent Market Insights

Global Life Science Products Market: Restraints

High cost of life science products is expected to hinder growth of the market. Development of novel products in the life science domain requires complex processes, which lead to expensive products.

Moreover, several users do not prefer to invest in such expensive products, especially for research groups with limited budgets and funding, due to the uncertainties in the results expected from complex experiments. Most of the research products procured from different vendors tend to show ambiguous results and products have also been known to have lot-to-lot variability. Therefore, researchers find it difficult to reproduce published research, thereby severely limiting progress of research. Such scenarios are expected to limit growth of the market.

Global Life Science Products Market: Opportunities 

Market players may focus on expanding their presence in emerging regions. Biotech projects can be outsourced in emerging economies such as India, owing to significant availability of skilled labor and qualified manpower at affordable costs.

Increasing government initiatives to boost the life science sector is expected to offer lucrative growth opportunities for players in the market. For instance, in March 2020, the U.K. government pledged an investment of US$ 24.57 billion per year by 2024-25 in its budget for R&D investment, including in the life sciences.

Life Science Products  | Coherent Market Insights

Academic & Research Institutes segment in the global life science products market was valued at US$ 1,444.8 Mn in 2019 and is expected to reach US$ 1,967.6 Mn by 2027 at a CAGR of 3.9% during the forecast period.

Market Trends/Key Takeaways

The adoption of big data in the life science sector allowed market players to classify potential clients, thereby allowing them to offer appropriate content and to track the effectiveness of campaigns. However, in May 2018, the EU implemented the General Data Protection Regulation (GDPR), which strengthened the data protection laws. Therefore, market players need to reassess their policies to suit the European market.

The life science sector in Europe has witnessed an increase in the number of patents. For instance, according to the European Patent Office, in 2019, the pharmaceutical sector witnessed a 4.4% rise in number of patents over 2018, whereas and biotechnology sector recorded a rise of 1.7% over 2018.

Regulations

Life Science Products  | Coherent Market Insights

Global Life Science Products Market: Competitive Landscape

Major players operating in the global life science products market include, Abcam Plc., A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc., Crown Bioscience Inc., Genscript Biotech Corporation, Merck Millipore Limited, PerkinElmer Inc., Sigma Aldrich Corp., and Thermo Fisher Scientific Inc.

Global Life Science Products Market: Key Developments 

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in October 2019, Thermo Fisher Scientific Inc. launched Cytomat 2 C-LiN Series Automated Incubator, which is designed to offer cell growth and environmental control across a range of micro plate applications that include cell-based screening, immuno-capture assays, microbiology, and enzyme testing.

Major players in the market are also focused on conducting clinical trials to expand their product portfolio. For instance, in March 2020, Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, presented additional analyses from the ORCA-1 Phase 2b trial that assessed the efficacy of ‘Cytisinicline’, a plant-based alkaloid with a high binding affinity to the α4β2 nicotine receptor, at the SRNT Annual Meeting in New Orleans (U.S).

Life science products include laboratory supplies & accessories, cell culture & fermentation processes, cell therapy technologies, chromatography products, bioprocess filtration, fixed and live cell research through imaging and analysis, sample collection products, recombinant proteins, cell lines, and antibodies. These products are used for drug discovery, tissue engineering, drug screening, forensic testing, and genetic analysis. Increasing funding in the life science sector is expected to boost growth of the global life science products market over the forecast period. Moreover, R&D in rare diseases is also expected to aid in growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the Life Science Products market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Life Science Products market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abcam Plc., A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc., Crown Bioscience Inc., Genscript Biotech Corporation, Merck Millipore Limited, PerkinElmer Inc., Sigma Aldrich Corp., and Thermo Fisher Scientific Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Life Science Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Life Science Products market

Detailed Segmentation:

  • Life Science Products Market, By Product:
    • Recombinant Proteins
      • Immune Checkpoint Regulators
      • Chemokines
      • Growth Factors
      • Cytokines
      • Colony Stimulating Factors
      • Hormones
      • Enzymes & Inhibitors
      • Others
    • Cell Lines
      • Immunotherapy Cell Lines
      • Ion Channel Cell Lines
      • GPCR Cell Lines
      • Cell Signaling Pathway Cell Lines
      • Gene Knockout Cell Lines
      • Cancer Cell Lines
      • Others
    • Antibodies
      • Immune Checkpoint Antibodies
      • Epitope Tag Antibodies
      • Isotype Control Antibodies
        • Research Use
        • In-vivo Grade
      • Primary Antibodies
        • Research Use
        • In-vivo Grade
    • Assay Antibodies (includes secondary antibodies)
    • Others
      • Viable Tumor Samples
      • Tumor Tissue Microarrays
  • Life Science Products Market, By Application:
    • Drug Discovery & Development
    • Basic Research
    • Toxicity Screening
    • Biopharmaceutical Production
    • Drug Screening
    • Tissue Engineering
    • Forensic Testing
  • Life Science Products Market, By End User:
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Academic & Research Institutes
    • Forensic Science Laboratories
    • Food & Beverage Companies
    • Diagnostic Centers
    • Others 
  • Life Science Products Market, By Region:
    • North America
      • By Product:
        • Recombinant Proteins
          • Immune Checkpoint Regulators
          • Chemokines
          • Growth Factors
          • Cytokines
          • Colony Stimulating Factors
          • Hormones
          • Enzymes & Inhibitors
          • Others
        • Cell Lines
          • Immunotherapy Cell Lines
          • Ion Channel Cell Lines
          • GPCR Cell Lines
          • Cell Signaling Pathway Cell Lines
          • Gene Knockout Cell Lines
          • Cancer Cell Lines
          • Others
        • Antibodies
          • Immune Checkpoint Antibodies
          • Epitope Tag Antibodies
          • Isotype Control Antibodies
            • Research Use
            • In-vivo Grade
          • Primary Antibodies
            • Research Use
            • In-vivo Grade
          • Assay Antibodies (includes secondary antibodies)
          • Others
        • Viable Tumor Samples
        • Tumor Tissue Microarrays
      • By Application
        • Drug Discovery & Development
        • Basic Research
        • Toxicity Screening
        • Biopharmaceutical Production
        • Drug Screening
        • Tissue Engineering
        • Forensic Testing
      • By End User
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Academic & Research Institutes
        • Forensic Science Laboratories
        • Food & Beverage Companies
        • Diagnostic Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product:
        • Recombinant Proteins
          • Immune Checkpoint Regulators
          • Chemokines
          • Growth Factors
          • Cytokines
          • Colony Stimulating Factors
          • Hormones
          • Enzymes & Inhibitors
          • Others
        • Cell Lines
          • Immunotherapy Cell Lines
          • Ion Channel Cell Lines
          • GPCR Cell Lines
          • Cell Signaling Pathway Cell Lines
          • Gene Knockout Cell Lines
          • Cancer Cell Lines
          • Others
        • Antibodies
          • Immune Checkpoint Antibodies
          • Epitope Tag Antibodies
          • Isotype Control Antibodies
            • Research Use
            • In-vivo Grade
          • Primary Antibodies
            • Research Use
            • In-vivo Grade
          • Assay Antibodies (includes secondary antibodies)
          • Others
        • Viable Tumor Samples
        • Tumor Tissue Microarrays
      • By Application
        • Drug Discovery & Development
        • Basic Research
        • Toxicity Screening
        • Biopharmaceutical Production
        • Drug Screening
        • Tissue Engineering
        • Forensic Testing
      • By End User
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Academic & Research Institutes
        • Forensic Science Laboratories
        • Food & Beverage Companies
        • Diagnostic Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product:
        • Recombinant Proteins
          • Immune Checkpoint Regulators
          • Chemokines
          • Growth Factors
          • Cytokines
          • Colony Stimulating Factors
          • Hormones
          • Enzymes & Inhibitors
          • Others
        • Cell Lines
          • Immunotherapy Cell Lines
          • Ion Channel Cell Lines
          • GPCR Cell Lines
          • Cell Signaling Pathway Cell Lines
          • Gene Knockout Cell Lines
          • Cancer Cell Lines
          • Others
        • Antibodies
          • Immune Checkpoint Antibodies
          • Epitope Tag Antibodies
          • Isotype Control Antibodies
            • Research Use
            • In-vivo Grade
          • Primary Antibodies
            • Research Use
            • In-vivo Grade
          • Assay Antibodies (includes secondary antibodies)
          • Others
        • Viable Tumor Samples
        • Tumor Tissue Microarrays
      • By Application
        • Drug Discovery & Development
        • Basic Research
        • Toxicity Screening
        • Biopharmaceutical Production
        • Drug Screening
        • Tissue Engineering
        • Forensic Testing
      • By End User
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Academic & Research Institutes
        • Forensic Science Laboratories
        • Food & Beverage Companies
        • Diagnostic Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product:
        • Recombinant Proteins
          • Immune Checkpoint Regulators
          • Chemokines
          • Growth Factors
          • Cytokines
          • Colony Stimulating Factors
          • Hormones
          • Enzymes & Inhibitors
          • Others
        • Cell Lines
          • Immunotherapy Cell Lines
          • Ion Channel Cell Lines
          • GPCR Cell Lines
          • Cell Signaling Pathway Cell Lines
          • Gene Knockout Cell Lines
          • Cancer Cell Lines
          • Others
        • Antibodies
          • Immune Checkpoint Antibodies
          • Epitope Tag Antibodies
          • Isotype Control Antibodies
            • Research Use
            • In-vivo Grade
          • Primary Antibodies
            • Research Use
            • In-vivo Grade
          • Assay Antibodies (includes secondary antibodies)
          • Others
        • Viable Tumor Samples
        • Tumor Tissue Microarrays
      • By Application
        • Drug Discovery & Development
        • Basic Research
        • Toxicity Screening
        • Biopharmaceutical Production
        • Drug Screening
        • Tissue Engineering
        • Forensic Testing
      • By End User
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Academic & Research Institutes
        • Forensic Science Laboratories
        • Food & Beverage Companies
        • Diagnostic Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product:
        • Recombinant Proteins
          • Immune Checkpoint Regulators
          • Chemokines
          • Growth Factors
          • Cytokines
          • Colony Stimulating Factors
          • Hormones
          • Enzymes & Inhibitors
          • Others
        • Cell Lines
          • Immunotherapy Cell Lines
          • Ion Channel Cell Lines
          • GPCR Cell Lines
          • Cell Signaling Pathway Cell Lines
          • Gene Knockout Cell Lines
          • Cancer Cell Lines
          • Others
        • Antibodies
          • Immune Checkpoint Antibodies
          • Epitope Tag Antibodies
          • Isotype Control Antibodies
            • Research Use
            • In-vivo Grade
          • Primary Antibodies
            • Research Use
            • In-vivo Grade
          • Assay Antibodies (includes secondary antibodies)
          • Others
        • Viable Tumor Samples
        • Tumor Tissue Microarrays
      • By Application
        • Drug Discovery & Development
        • Basic Research
        • Toxicity Screening
        • Biopharmaceutical Production
        • Drug Screening
        • Tissue Engineering
        • Forensic Testing
      • By End User
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Academic & Research Institutes
        • Forensic Science Laboratories
        • Food & Beverage Companies
        • Diagnostic Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product:
        • Recombinant Proteins
          • Immune Checkpoint Regulators
          • Chemokines
          • Growth Factors
          • Cytokines
          • Colony Stimulating Factors
          • Hormones
          • Enzymes & Inhibitors
          • Others
        • Cell Lines
          • Immunotherapy Cell Lines
          • Ion Channel Cell Lines
          • GPCR Cell Lines
          • Cell Signaling Pathway Cell Lines
          • Gene Knockout Cell Lines
          • Cancer Cell Lines
          • Others
        • Antibodies
          • Immune Checkpoint Antibodies
          • Epitope Tag Antibodies
          • Isotype Control Antibodies
            • Research Use
            • In-vivo Grade
          • Primary Antibodies
            • Research Use
            • In-vivo Grade
          • Assay Antibodies (includes secondary antibodies)
          • Others
        • Viable Tumor Samples
        • Tumor Tissue Microarrays
      • By Application
        • Drug Discovery & Development
        • Basic Research
        • Toxicity Screening
        • Biopharmaceutical Production
        • Drug Screening
        • Tissue Engineering
        • Forensic Testing
      • By End User
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Academic & Research Institutes
        • Forensic Science Laboratories
        • Food & Beverage Companies
        • Diagnostic Centers
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abcam Plc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • A.M.S. Biotechnology (Europe) Limited
    • Bio-Rad Laboratories Inc.
    • BPS Bioscience Inc.
    • Crown Bioscience Inc.
    • Genscript Biotech Corporation
    • Merck Millipore Limited
    • PerkinElmer Inc.
    • Sigma Aldrich Corp.
    • Thermo Fisher Scientific Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Life Science Products Market, By Product, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Recombinant Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Immune Checkpoint Regulators
        • Chemokines
        • Growth Factors
        • Cytokines
        • Colony Stimulating Factors
        • Hormones
        • Enzymes & Inhibitors
        • Others
    • Cell Lines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Immunotherapy Cell Lines
        • Ion Channel Cell Lines
        • GPCR Cell Lines
        • Cell Signaling Pathway Cell Lines
        • Gene Knockout Cell Lines
        • Cancer Cell Lines
        • Others
    • Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Immune Checkpoint Antibodies
        • Epitope Tag Antibodies
        • Isotype Control Antibodies
          • Research Use
          • In-vivo Grade
        • Primary Antibodies
          • Research Use
          • In-vivo Grade
        • Assay Antibodies (includes secondary antibodies)
        • Others
    • Viable Tumor Samples
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Tumor Tissue Microarrays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Life Science Products Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Drug Discovery & Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Basic Research
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Toxicity Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Biopharmaceutical Production
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Tissue Engineering
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Forensic Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Life Science Products Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Contract Research Organizations (CROs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic & Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Forensic Science Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Food & Beverage Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Life Science Products Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • Abcam Plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • A.M.S. Biotechnology (Europe) Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BPS Bioscience Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Crown Bioscience Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Genscript Biotech Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck Millipore Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • PerkinElmer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sigma Aldrich Corp.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 28 market data tables and 18 figures on “Life Science Products Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner